[Testosterone and congestive heart failure]

T N Enina1, V A Kuznetsov1, A M Soldatova1

  • 1Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Tomsk.

Kardiologiia
|August 22, 2022
PubMed

Insights

Low testosterone is common in chronic heart failure (CHF). This review examines testosterone

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Chronic heart failure (CHF) is a complex condition with various contributing factors.
  • Testosterone plays a role in cardiovascular health, and its deficiency is increasingly recognized in specific patient populations.

Purpose of the Study:

  • To review the current literature on the relationship between testosterone levels and chronic heart failure.
  • To explore the impact of testosterone on the cardiovascular system and its relevance in CHF patients.

Main Methods:

  • Systematic review of key publications.
  • Analysis of studies investigating testosterone deficiency prevalence in CHF.
  • Examination of research on testosterone's cardiovascular effects.
  • Evaluation of the link between testosterone levels and CHF severity/prognosis.
  • Assessment of interventional treatment efficacy for CHF in relation to testosterone.

Main Results:

  • Testosterone deficiency is prevalent in patients with chronic heart failure.
  • Endogenous and exogenous testosterone have significant effects on the cardiovascular system.
  • Lower testosterone levels correlate with increased CHF severity and poorer prognosis.
  • Interventional treatments for CHF may be influenced by testosterone status.

Conclusions:

  • The interrelation between testosterone and chronic heart failure is significant.
  • Monitoring and potentially treating testosterone deficiency may be important in managing CHF patients.
  • Further research is warranted to elucidate optimal therapeutic strategies.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
45
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
39
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
423